Ocugen

Ocugen Inc. (NASDAQ: OCGN) is a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure blindness diseases. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug – “one to many” and our novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy.

Website : https://www.ocugen.com
Industry : Biotechnology
Company size : 11-50 employees
Headquarters : Malvern, Pennsylvania
Type : Public Company
Founded : 2013
Specialties : ophthalmology, biopharmaceutical, biotechnology, therapeutics biologics, rare diseases, inherited retinal disorders, and wet AMD
Willful Violator: No  
H1B Dependent: No  
Economic Sector: n.a.
NAICS Industry: Biotechnology

LCA filing for H1B Visa Jobs
2020 : 0
2019 : 0
2018 : 0
2017 : 0
2016 : 0
2015 : 0
2014 : 0
2013 : 0
2012 : 0
2011 : 0

LC filing for green card under PERM
2020 : 0
2019 : 0
2018 : 0
2017 : 0
2016 : 0
2015 : 0
2014 : 0
2013 : 0
2012 : 0
2011 : 0